Thursday, 22 May 2025
An expert from the 糖心原创, whose research is vital in helping to improve the quality of life and care of people with dementia, has been awarded a Fellowship from the Academy of Medical Sciences.
Professor Sube Banerjee, MBE, Pro-Vice-Chancellor for the Faculty of Medicine and Health Sciences, and Professor of Dementia at the 糖心原创, is one of 54 exceptional biomedical and health scientists to be recognised by the Academy. The group are being awarded the Fellowships for their remarkable contribution to advancing medical science, groundbreaking research discoveries and translating developments into benefits for patients and the wider public.
Professor Banerjee is internationally preeminent in applied health research and policy in dementia. Driven by desire to improve the quality of life of people with dementia by improving care quality, over 30 years he has done precisely that. His research, clinical innovation and health policy/strategy have been instrumental in bringing dementia out of the shadows to be a major priority worldwide. He combines excellence in research with direct involvement in formulation, delivery and communication of policy, strategy and change, nationally and internationally.
He led the development and delivery of England’s National Dementia Strategy improving public understanding, diagnostic services and post-diagnostic care, and worked with WHO on global dementia policy. His independent ministerial report on antipsychotic use in dementia, and his RCTs (SADD, SYMBAD), changed the evidence base and clinical behaviour, so frail older people are not exposed to ineffective drugs with major adverse effects, saving over 1,000 lives annually.
He has championed under-served groups with research into barriers to care for people from minority ethnic groups and leads DETERMIND, the world’s largest research programme into inequalities and inequities in dementia outcomes and care. Fundamental research on quality of life gave the experience of people with dementia a voice in research through the world-leading DEMQOL system. New models of memory services enabled the doubling (to 67%) of UK dementia diagnosis rates, with international uptake.
I am delighted and immensely honoured to have been elected a Fellow of the Academy of Medical Sciences. This is only possible because of the fantastic creative thoughts and actions of the researchers, clinicians and most importantly the people with dementia and their families who have worked with me over the years to improve the quality of life and quality of care of people with dementia."
"The Academy of Medical Sciences has a critical role in our national research ecosystem and I look forward to working with them to continue to build health science and practice that really improves patient care and does so equitably.”
Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said: “It is a privilege to welcome these 54 exceptional scientists to our Fellowship. Each new Fellow brings unique expertise and perspective to addressing the most significant health challenges facing society.
“The breadth of disciplines represented in this year’s cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.”
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.